3 years ago
MRK
AnalystsNarumi NakagiriNarumi Nakagiri's Stock Forecasts
AnalystsNarumi Nakagiri
Sectors:
Analyst Ranking
Bottom 22%
#3938 out of 4989 analysts
Average Return
-7.66%
Win Rate
20%1 out of 5
Risk vs Reward
Poor
Good
Narumi Nakagiri's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Merck & Co IncMRK | +20.15% | $93.01 | $111.75 | 2022‑07‑06 - 2023‑07‑06 | Buy |
Narumi Nakagiri Analyst Color
Get additional color on Narumi Nakagiri's coverage of popular stocks
Narumi Nakagiri's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Illumina IncILMN | 1 | Strong Buy | $154.00 | N/A | Upgrades | a year ago |
Pfizer IncPFE | 3 | Buy | $34.00 | N/A | Upgrades | a year ago |
Johnson & JohnsonJNJ | 1 | Hold | $150.00 | N/A | Downgrades | a year ago |
Amgen IncAMGN | 2 | Strong Buy | $320.00 | N/A | Upgrades | 2 years ago |
Bristol Myers Squibb CoBMY | 1 | Hold | $54.00 | N/A | Downgrades | 2 years ago |
Merck & Co IncMRK | 1 | Buy | $102.00 | N/A | Upgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.